世界の食品アレルギー市場の規模、シェア、トレンド分析レポート – 業界の概要と2032年までの予測

Get Exclusive Sample PDF of this Report Here

食品アレルギー市場分析

世界の食物アレルギー市場は、世界中で重大な公衆衛生上の懸念となっている食物アレルギーの罹患率の上昇によって牽引されています。世界アレルギー機構 (WAO) によると、世界で約 2 億 2,000 万～ 2 億 5,000 万人が食物アレルギーに苦しんでおり、その罹患率が最も高いのは 5 歳未満の子供です。米国では、子供の 5 ～ 8%、成人の 2 ～ 3% が食物アレルギーに悩まされており、子供の間ではピーナッツと牛乳のアレルギーが最も一般的であるとの調査報告があります。同様に、欧州アレルギー・臨床免疫アカデミー (EAACI) によると、欧州では、子供の約 6 ～ 8%、成人の 3 ～ 4% が食物アレルギーに悩まされています。特に子供の間で重度のアレルギー反応によるアナフィラキシー症例の報告数が増加していることから、この市場では効果的な診断および治療ソリューションの必要性が高まっていることが浮き彫りになっています。この傾向は、開発途上地域での環境要因と食習慣の変化によってさらに悪化しています。

食品アレルギー市場規模

世界の食物アレルギー市場規模は、2024年に28億4,000万米ドルと評価され、2025年から2032年の予測期間中に9.40%のCAGRで成長し、2032年には59億4,000万米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

食品アレルギー市場の動向

「診断ツールの採用増加」

高度な診断技術の導入により、食物アレルギーの特定および管理方法が変わりつつあります。分子アレルギー学および成分分解診断 (CRD) は、食品内の特定のアレルギー性タンパク質を正確に検出する手法として登場しており、個人の感受性をより詳細に理解することを可能にします。従来の皮膚プリックテストや血清 IgE 測定とは異なり、これらの高度なツールは、反応を引き起こすアレルギー性成分を正確に特定することで精度を向上させます。これにより、古い診断方法でよく見られる偽陽性の発生が減り、不必要な食事制限が最小限に抑えられます。これらの革新は、異なる食品グループ間の交差反応性など、複雑なアレルギーの場合に特に有益であり、医療従事者が的を絞った管理プランを策定できるようにします。これらのツールの認知度が高まるにつれて、臨床診療や研究にますます統合され、より効果的で個別化されたアレルギー治療に貢献しています。

レポートの範囲と食品アレルギー市場のセグメンテーション

Get Exclusive Sample PDF of this Report Here

食品アレルギー 市場の定義

食物アレルギーは、特定の食品に含まれる特定のタンパク質によって引き起こされる有害な免疫システムの反応です。これは、体の免疫システムが無害な食品タンパク質を誤って有害で​​あると認識し、ヒスタミンなどの化学物質を放出することで発生し、軽度（じんましん、かゆみ、胃痛など）から重度（アナフィラキシー、生命を脅かす反応など）までさまざまな症状を引き起こします。一般的なアレルゲンには、ピーナッツ、木の実、牛乳、卵、小麦、大豆、魚、甲殻類などがあります。食物不耐症とは異なり、食物アレルギーは免疫反応を伴うため、アレルゲンが少量でも発生する可能性があります。

食品アレルギー市場の動向

ドライバー  

• 食物アレルギーの増加

世界中で、特に子供の間で食物アレルギーの罹患率が上昇していることは、食物アレルギー市場の成長に影響を与える重要な要因です。研究によると、食物アレルギーは子供の約5〜8％、成人の2〜3％に影響を与えており、最も一般的な誘因はピーナッツ、木の実、牛乳、卵、甲殻類です。この症状は幼少期に現れることが多く、多くの場合、個人はこれらのアレルギーを成人期まで持ち続けるため、効果的な管理ソ​​リューションの長期的なニーズが高まります。アナフィラキシーなどの重篤な反応は、タイムリーな診断と介入の重要性を浮き彫りにします。親、介護者、医療提供者の間で食物アレルギーに関する認識が高まっているため、正確な診断ツールやエピネフリン自動注射器などの緊急治療の需要が高まっています。さらに、アレルギーのある個人の食事ニーズに対応するために、アレルゲンフリーの食品の人気が高まっています。食物アレルギーの罹患率の増加は、革新的な診断および治療ソリューションの必要性を強調し、急速に進化するこの市場の進歩を促進します。  

• 診断技術の進歩   

Advancements in diagnostic technologies are significantly enhancing the precision and reliability of food allergy identification. Techniques such as component-resolved diagnostics (CRD) and molecular allergology provide detailed insights by identifying specific allergenic proteins rather than entire food groups. This level of accuracy enables healthcare providers to differentiate between true allergies and cross-reactivities, reducing the false positives commonly associated with traditional methods such as skin prick tests and serum IgE testing. By minimizing unnecessary dietary restrictions and ensuring targeted treatment plans, these tools are improving patient outcomes. Additionally, the growing adoption of these technologies in clinical settings reflects their effectiveness in managing complex allergy cases, such as those involving multiple allergens or severe reactions. The continuous refinement of these diagnostic methods is further supported by ongoing research and integration into routine healthcare practices. Advanced diagnostic technologies are transforming food allergy management, ensuring greater accuracy in detection and paving the way for personalized patient care.

Opportunities

• Growth in Allergen-Free Food Products

The rising awareness of food allergies is driving an increasing demand for allergen-free and "free-from" food products, offering significant opportunities for food manufacturers. With more consumers becoming conscious of potential allergens such as peanuts, milk, eggs, and gluten, there is a growing preference for foods that are free from these common triggers. This trend is not only impacting individuals with diagnosed food allergies but also families seeking to provide safer food options for children. As a result, manufacturers have the chance to innovate and expand their product offerings to meet this demand, creating allergen-free versions of popular foods across various categories such as snacks, dairy, and baked goods. The availability of these products in both mainstream grocery stores and specialty markets further amplifies the growth potential. As the market for allergen-free food products continues to expand, companies that can effectively cater to this need will likely see increased market share. The demand for allergen-free foods presents a lucrative opportunity for manufacturers to diversify their product lines and tap into the growing consumer base seeking safe, allergen-conscious options.

• Development of Immunotherapies and Vaccines

The development of immunotherapies and vaccines presents a promising opportunity in the food allergy market. Oral immunotherapy (OIT), subcutaneous immunotherapy, and vaccines are being researched to help desensitize individuals to specific allergens, aiming to alter the immune response and reduce the severity of allergic reactions. These treatments are designed to gradually expose the immune system to small amounts of allergens, training it to tolerate them over time. This approach could significantly improve the quality of life for individuals with food allergies, reducing the risk of life-threatening reactions and minimizing the need for emergency interventions. Ongoing research and clinical trials are exploring the potential of these therapies, and breakthrough treatments could revolutionize food allergy management in the future. With these innovations on the horizon, the food allergy market is poised for long-term growth as new therapies become available. The development of immunotherapies and vaccines represents a transformative opportunity to enhance treatment options for food allergy sufferers, driving growth and innovation in the market.

Restraints/Challenges

• High Cost of Treatment and Diagnostics

The high cost of treatment and diagnostics presents a significant restraint on the growth of the global food allergy market. Advanced therapies such as oral immunotherapy (OIT), subcutaneous immunotherapy, and vaccines, as well as specialized diagnostic tools such as component-resolved diagnostics (CRD) and molecular allergology, require extensive research, development, and production, leading to high costs. These treatments and diagnostic procedures are often expensive for patients, particularly in regions where healthcare access is limited or insurance coverage is insufficient. The financial burden of these advanced options can make them inaccessible to a large segment of the population, slowing the adoption of innovative therapies and technologies. Additionally, the high cost of allergen-free food products also contributes to this barrier, especially for low-income families. As a result, the widespread use of these solutions may be limited, slowing the overall growth of the food allergy market. The high cost of treatment and diagnostics is a major restraint on the Global Food Allergy Market, limiting access to advanced solutions and slowing market expansion.

• Lack of Standardized Treatment Protocols

The lack of standardized treatment protocols poses a significant challenge in the global food allergy market. Although therapies such as oral immunotherapy (OIT) and vaccines have shown potential in managing food allergies, there is no universally accepted guideline for their use. The effectiveness and safety of these therapies can vary greatly depending on the individual, allergen type, and the severity of the allergy, making it challenging for healthcare providers to deliver consistent, evidence-based care. This lack of standardization can lead to varying patient outcomes, creating confusion for both healthcare professionals and patients. Furthermore, regional differences in healthcare infrastructure, access to resources, and levels of awareness exacerbate the issue, complicating the implementation of standardized treatment approaches. The absence of clear, globally recognized treatment protocols delays the adoption of innovative therapies, limiting their widespread application and slowing progress in food allergy management. The lack of standardized treatment protocols remains a major challenge, hindering the effective and consistent management of food allergies and impeding global progress in patient care.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.

Food Allergy Market Scope

The market is segmented on the basis of allergen type, diagnosis, treatment, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Allergen Type

• Peanuts
• Tree Nuts
• Milk
• Eggs
• Wheat
• Soy
• Fish
• Shellfish
• Others

Diagnosis

• Skin Prick Tests (SPT)
• Blood Tests (IgE Tests)
• Oral Food Challenge (OFC)
• Patch Testing, Others

Treatment

• Anti-Histamines
• Epinephrine Auto-Injectors
• Immunotherapy
• Dietary Management, Others

End User

• Hospitals
• Clinics
• Diagnostic Centers
• Homecare

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Food Allergy Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, allergen type, diagnosis, treatment, end user, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to its advanced healthcare infrastructure, which supports early diagnosis and effective management of food allergies. High awareness among the population and substantial investments in research and development for innovative treatments and diagnostic technologies further contribute to the region's leadership, enabling improved patient outcomes and fueling market growth.

Asia-Pacific is expected to be the fastest growing due to the rising prevalence of food allergies, particularly in densely populated countries such as India and China, where changing diets and lifestyles contribute to increased cases. Improved healthcare access and growing awareness of allergy management and treatments in emerging economies are driving demand for advanced diagnostic and therapeutic solutions, fostering robust market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Food Allergy Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Food Allergy Market Leaders Operating in the Market Are:

• ALK (Denmark)
• Nestlé Health Science (Switzerland)
• Aimmune Therapeutics, Inc. (U.S.)
• Sanofi S.A. (France)
• Stallergenes Greer Ltd. (U.K.)
• DBV Technologies (France)
• Allergy Therapeutics Plc (U.K.)
• Prota Therapeutics Pty Ltd. (Australia)
• Aravax Pty Ltd. (Australia)
• Johnson & Johnson Services, Inc. (U.S.)
• Pfizer Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• EpiGuard (Norway)
• Medline Industries, LP (U.S.)
• HAL Allergy B.V. (Netherlands)
• テバ製薬工業株式会社（イスラエル）
• ビアトリス社（米国）

世界の食品アレルギー市場の最新動向

• 2024年9月、三菱ガス化学株式会社は、デトロイトを拠点とするヘルステック企業Alerje社と提携し、救急医療および食物アレルギー管理プラットフォームを通じてアレルギーケアを強化します。このコラボレーションにより、三菱はアレルギーケア分野で革新を起こし、ヘルスケアテクノロジーの範囲を拡大します。
• 2024年7月、BioVaxys Technology Corp.は、AP Visionaries Inc.と拘束力のある意向書に署名し、ピーナッツ、木の実、卵によって引き起こされる食物アレルギーを含む、生命を脅かす食物アレルギーの治療を目的とした独自のDPX製剤を共同開発します。このコラボレーションにより、BioVaxysは免疫教育療法のポートフォリオを拡大し、革新的なアレルギー治療を前進させることができます。
• 2024年2月、FDAはNIHが後援する第3相OUtMATCH研究のデータに基づき、1つ以上の食物アレルギーを持つ子供と大人に対する最初で唯一の治療薬としてゾレアを承認しました。この承認により、同社は食物アレルギー治療におけるゾレアの市場の可能性を拡大し、患者に新たな選択肢を提供することができます。
• 2024年1月、Inimmune CorporationとIntrommune Therapeutics, Inc.は、Intrommuneのピーナッツ口腔粘膜免疫療法（OMIT）とInimmuneの急速アレルゲン脱感作免疫療法を組み合わせる戦略的提携を発表しました。この提携により、両社は食物アレルギー治療を前進させ、革新的な免疫療法の開発を加速することができます。
• 2024年1月、イントロミューン・セラピューティクスは、ピーナッツアレルギーの治療を目的とした新しい歯磨き粉INT301の第2相臨床試験を開始しました。この開発により、同社は食物アレルギー治療パイプラインを前進させ、革新的なソリューションを市場に投入できるようになります。

SKU-54391